Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Meilinger, M; Stoeckl, C; Pollheimer, M; Kern, P; Reisinger, EC; Seeber, K; Krause, R; Flick, H; Hoenigl, M.
Progressive alveolar echinococcosis after discontinuation of anthelmintic therapy.
Parasit Vectors. 2013; 6(1):287-287
Doi: 10.1186/1756-3305-6-287
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Flick Holger
-
Hönigl Martin
-
Meilinger Michael
- Co-Autor*innen der Med Uni Graz
-
Krause Robert
-
Pollheimer Marion
-
Stöckl Christina
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
We report a case of a female patient with alveolar echinococcosis (AE) who presented with progressive pulmonary and hepatic lesions and had a fatal outcome. AE affecting the liver, the lungs and the brain had been diagnosed 20 years ago and treated successfully with albendazole and stereotactic gamma knife therapy. Due to severe hair loss albendazole was stopped 14 years before presentation. Lesions had remained stable in imaging studies for at least 11 years, but then had started to progress. Lifelong anthelmintic maintenance therapy and regular follow-up may therefore be crucial in order to prevent such a dramatic clinical course.
- Find related publications in this database (using NLM MeSH Indexing)
-
Anthelmintics - administration & dosage
-
Brain - parasitology
-
Echinococcosis, Hepatic - diagnosis
-
Fatal Outcome -
-
Female -
-
Humans -
-
Liver - parasitology
-
Lung - parasitology
-
Middle Aged -
-
Withholding Treatment -
- Find related publications in this database (Keywords)
-
Alveolar echinococcosis
-
Echinococcus multilocularis
-
Albendazole
-
Anthelmintic therapy
-
Liposomal amphotericin B